[HTML][HTML] Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis?

AM Arafat, M Skrzypski, E Pruszyńska-Oszmalek… - Diabetologia, 2013 - Springer
Aims/hypothesis Glucagon reduces body weight by modifying food intake, glucose/lipid
metabolism and energy expenditure. All these physiological processes are also controlled …

[PDF][PDF] Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis?

AM Arafat, P Kaczmarek, M Skrzypski… - Diabetologia, 2013 - researchgate.net
Aims/hypothesis Glucagon reduces body weight by modifying food intake, glucose/lipid
metabolism and energy expenditure. All these physiological processes are also controlled …

[引用][C] Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis?

AM ARAFAT, P KACZMAREK, KW NOWAK… - Diabetologia …, 2013 - pascal-francis.inist.fr
Author ARAFAT, A. M 1 2; KACZMAREK, P 3; NOWAK, K. W 3; STROWSKI, M. Z 4;
SKRZYPSKI, M 3; PRUSZYŃSKA-OSZMALEK, E 3; KOŁODZIEJSKI, P 3; …

Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis?

AM Arafat, P Kaczmarek, M Skrzypski… - Diabetologia, 2012 - europepmc.org
Methods The effects of exogenous glucagon on plasma FGF-21 levels and lipolysis were
evaluated in healthy volunteers and humans with type 1 diabetes, as well as in rodents with …

Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis?

AM Arafat, P Kaczmarek, M Skrzypski… - …, 2013 - search.proquest.com
Glucagon reduces body weight by modifying food intake, glucose/lipid metabolism and
energy expenditure. All these physiological processes are also controlled by fibroblast …

[PDF][PDF] Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis?

AM Arafat, P Kaczmarek, M Skrzypski… - Diabetologia, 2013 - academia.edu
Aims/hypothesis Glucagon reduces body weight by modifying food intake, glucose/lipid
metabolism and energy expenditure. All these physiological processes are also controlled …

[引用][C] Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis?

AM Arafat, P Kaczmarek, M Skrzypski… - Diabetologia, 2012 - cir.nii.ac.jp
Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin
levels: a novel mechanism of glucagon-stimulated lipolysis? | CiNii Research CiNii 国立情報学 …

Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis?

AM Arafat, P Kaczmarek, M Skrzypski… - Diabetologia, 2013 - infona.pl
Aims/hypothesis Glucagon reduces body weight by modifying food intake, glucose/lipid
metabolism and energy expenditure. All these physiological processes are also controlled …

Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis?

AM Arafat, P Kaczmarek, M Skrzypski… - …, 2013 - pubmed.ncbi.nlm.nih.gov
Aims/hypothesis Glucagon reduces body weight by modifying food intake, glucose/lipid
metabolism and energy expenditure. All these physiological processes are also controlled …

Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis?

AM ARAFAT, P KACZMAREK, M SKRZYPSKI… - Diabetologia, 2013 - cat.inist.fr
Aims/hypothesis Glucagon reduces body weight by modifying food intake, glucose/lipid
metabolism and energy expenditure. All these physiological processes are also controlled …